JPMORGAN CHASE & CO - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is and the CUSIP is 10778Y902. A total of 3 filers reported holding BRIACELL THERAPEUTICS CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q1 2022$436,00043,0000.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q2 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
SIMPLEX TRADING, LLC 75,200$433,0000.00%
JANE STREET GROUP, LLC 65,900$380,0000.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders